| Robert Lacy, DO | |
|
3496 E Lake Lansing Rd, East Lansing, MI 48823-2288 | |
| (517) 333-0968 | |
| Not Available |
| Full Name | Robert Lacy |
|---|---|
| Gender | Male |
| Speciality | General Practice |
| Location | 3496 E Lake Lansing Rd, East Lansing, Michigan |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144489659 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | 5101015868 (Michigan) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Robert Lacy, DO 3496 E Lake Lansing Rd, East Lansing, MI 48823 Ph: () - | Robert Lacy, DO 3496 E Lake Lansing Rd, East Lansing, MI 48823-2288 Ph: (517) 333-0968 |
News Archive
Molecular DNA testing methods offer clinicians powerful tools that serve to confirm or identify disease diagnoses. High sensitivity and high specificity, however, are frequently a challenge to achieve with these methods. In a study scheduled for publication in the November issue of The Journal of Molecular Diagnostics, researchers describe a new, robust technique that holds promise for identifying trace mutant DNA sequences in an overwhelming population of unmutated DNA.
Shimmers leading wearable technology platform was selected as one of the 10 Most Promising Patient Monitoring Solution Providers of 2017 by Healthcare Tech Outlook. Shimmer has been described as a company that is redefining the healthcare service delivery for all stakeholders, according to the May edition of the magazine released this week.
Protox Therapeutics Inc., a leader in the development of receptor targeted fusion proteins, today announced that two oral podium presentations on the company's lead candidate, PRX302, will be made at the 2010 Annual Meeting of the American Urological Association (AUA). These presentations will include six month data from the Phase 2b clinical study of PRX302 called TRIUMPH, in patients with moderate to severe benign prostatic hyperplasia (BPH).
An international study led by researchers at the John Wayne Cancer Institute at Saint John's Health Center has found that modifications to DNA found on multiple chromosomes in tumors can help to predict outcomes in patients with early-stage rectal cancer.
› Verified 4 days ago
Jonathan Henry, MD General Practice Medicare: Accepting Medicare Assignments Practice Location: 4572 South Hagadorn, 2a East, East Lansing, MI 48823 Phone: 517-349-8388 Fax: 517-349-1560 | |
Joni Lynn Rognon, D.O. General Practice Medicare: Not Enrolled in Medicare Practice Location: 1760 E Grand River Ave, East Lansing, MI 48823 Phone: 517-896-8693 Fax: 517-337-1778 | |
Dr. Muhammad Mustafa, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 3496 E Lake Lansing Rd, East Lansing, MI 48823 Phone: 517-333-0968 | |
Dr. Hector Luis Ramos, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 5370 Burcham Dr, East Lansing, MI 48823 Phone: 151-738-1982 | |
Dr. Paul Piper, General Practice Medicare: Not Enrolled in Medicare Practice Location: 3496 E Lake Lansing Rd, East Lansing, MI 48823 Phone: 517-333-0968 | |
Dr. Joanne Marie Westphal, D.O. General Practice Medicare: Not Enrolled in Medicare Practice Location: 211 Clarendon Rd, East Lansing, MI 48823 Phone: 517-333-8447 |